American Medical Association: AMA Drug Evaluations, 1st Ed., 1971.
2.
NewmanS., and WallaceJ. F.: Hypersensitivity and Connective Tissue Disorders, In: Diseases of Medical Progress: A Study of Iatrogenic Disease, MoserR. H., Ed., 3rd Edition, pp. 419. Charles C Thomas, Springfield, Ill.
3.
WittigH. J., WeltonW. A., and BurrellR.: A Primer on Immunologic Disorders, pp. 23–24. Charles C Thomas, Springfield, Ill., 1970.
4.
JamesL. P.Jr. and AustenK. F.: Fatal Systemic Anaphylaxis in Man. N. E. J. Med.270: 597–603, 1964.
5.
MacFarlaneM. D.: Allergic Drug Reactions, Drug Intell. Clin. Pharm.6: 342–348, 1972.
6.
IshizakaK., IshazakaT., and HornbrookN. M.: Physiochemical Properties of Human Reaginic Antibody. V. Correlations of Reaginic Activity with Gamma E Globulin Anitbody, J. Immunol.97: 840–853, 1966.
7.
ReismanR. E., and ArbesmanC. E.: Systemic Allergic Reactions Due to Inhalation of Penicillin, J. Am. Med. Assoc.203: 986–987, 1968.
8.
VanArsdelP.P.Jr., MiddletonE.Jr., ShermanW. B., and BuchwahdH.: A Quantitative Study on the In Vitro release of Histamine from Leukocytes in Atopic Persons, J. Allergy29: 429–437, 1958.
9.
LiacopoulosP., Liacopoulos-BriotT., BinaghiR. A., and PerramontF.: Correlation Entre la Desorption des Gamma-Globulines et la Sensibilisation Anaphylactique, Etude Release. In: Biochemistry of the Acute Allergic Reactions, A symposium. AustenK. F., and BeckerE. L., Eds. pp 99–113, F. A. Davis, Philadelphia, 1958.
10.
sur des Organes Isoles Sensibilises PassivementIn Vitro et In Vivo, Comp. Rend. Soc. Biol.155: 220–225, 1961.
11.
AustenK. F., and HumphreyJ. H.: In Vitro Studies on Anaphylaxis, Adv. Immunol.3: 1–96, 1963.
12.
BartoschR., FeldbergW., and NagelE.: Das Freiwerden eines Histaminahnlichen Stoffes bei der Anaphylaxie des Meerschweinchens, Pflugers Arch. Ges. Physiol.230: 120–153, 1932.
13.
SchildH. O.: Mechanism of Anaphylactic Histaminetion in Man, Brit. J. Pharmacol.4: 153–156, 1949.
14.
UnvasB.: The Mechanism of Histamine Liberation, J. Pharm. Pharmacol.10: 1–13, 1958.
15.
HaddyF. J.: Effect of Histamine on Small and Large Vessel Pressures in the Dog Foreleg, Amer. J. Physiol.198: 161–168, 1960.
16.
MajnoG., GilmoreV., and LeventhalM.: On the Mechanism of Vascular Leakage Caused by Histamine-Type Mediators, Circulation. Res.21: 833–847, 1967.
17.
RowleyD. A.: Venous Constriction as Cause for Increased Vascular Permeability Produced by 5-Hydroxytryptamine, Histamine, Bradykinin, and 48 80 in the Rat, Brit. J. Exper. Path.45: 56–67, 1964.
18.
KeeleC. A.: Chemical Causes of Pain and Itch, Ann. Rev. Med.21: 67–74, 1970
19.
AshfordC. A., HellerH., and SmartG. A.: The Action of Histamine on Hydrochloric Acid and Pepsin Secre-
20.
LecomteJ.: Liberation of Endogenous Histamine in Man, J. Allergy28: 102–112, 1957.
21.
BrocklehurstW. E.: The Release of Histamine and Formation of a Slow Reacting Substance SRS-A) During Anaphylactic Shock, J. Physiol. (Lond.).151: 416–435, 1960.
22.
ParishW. E.: Release of Histamine and Slow Reacting Substance with Mast Cell Changes after Challenge of Human Lung Sensitized Passively with Reagin in Rats, Nature215: 738–739, 1967.
23.
BrocklehurstW. E.: Slow Reacting Substance and Related Compounds, Prog. Allergy6: 539–558, 1962.
24.
CollierH. O. J., and JamesG. W. L.: Humoral Factors Affecting Pulmonary Inflation During Acute Anaphylaxis in the Guinea-Pig In Vivo, Brit. J. Pharmacol.30: 283–301, 1967.
25.
OrangeR. P., and AustenK. F.: Slow Reacting Substance of Anaphylaxis, Adv. Immunol.10: 105–144, 1969.
26.
ElliottD. F., LewisG. P., and HortonE. W.: Structure of Bradykinin: Plasma Kinin From Ox Blood, Biochem. Biophys. Research. Comm.3: 87–91, 1960.
27.
WerleE., TrautscholdI., and LeysathG.: Isoherung and Struktur des Kallidins, Hoppe Seyler's Zuisch. f. Physiol. Chem.326: 174–176, 1961.
28.
MargolisJ.: Hageman Factor and Capillary Permeability, Aust. J. Exp. Biol. Med. Sci.37: 239–244, 1959.
29.
MasonB., and MilesA. A.: Globulin Permeability Factors Without Kininogenase Activity, Nature.196: 587, 1962.
30.
Roche e SilvaM., BeraldoW. T., and RosenfeldG.: Bradykinin: Hypotensive and Smooth Muscle Stimulating Factor Released from Plasma Globulins by Snake Venoms and by Trypsin, Amer. J. Physiol.156: 261–273, 1949.
31.
GautvikK. M., and RugstadH. P.: Kinin Formation and Kininogen Depletion in Rats after Intravenous Injection of Ellagic Acid, Brit J. Pharmacol.31: 390–400, 1967.
32.
FerreiraS. H., and VaneJ. R.: The Disappearance of Bradykinin and Eledoisin in the Circulation and Vascular Beds of the Cat, Brit. J. Pharmacol.30: 417–424, 1965.
33.
MovatH. Z., DiLorenzoN. L., MustartJ. F., and HelmetG.: Activation of Hageman and Vascular Permeability Factor by Ab/Ag Precipitates, Fed. Proc.25: 682, 1966.
34.
JonassonO., and BeckerE. L. J.: Release of Kallikrein from Guinea-Pig Lung During Anaphylaxis, J. Expt. Med.123: 509–522, 1966.
35.
BrocklehurstW. E., and LahiriS. C.: The Production of Bradykinin in Anaphylaxis, J. Physiol. (Lond.).160: 15–16, 1962.
36.
AbeK., WatanbeN., KumagriN., MouriT., SkeiT., and YoshinagaK.: Circulating Kinin in Patients with Bronchial Asthma, Experientia23: 626–630, 1967.
37.
MichelB., RussellT., WinkelmannR. K., and GleichG. J.: Release of Kinins During Wheal and Flare Allergic Skin Reactions, J. Clin. Invest.47: 68a, 1968.
38.
ElliottD. F., HortonE. W., and LewisG. P.: Actions of Pure Bradykinin, J. Physiol. (Lond.).153: 437–480, 1960.
39.
MasonD. T., and MelmonK. L.: Effects of Bradykinin on Forearm Venous Tone and Vascular Resistance in Man, Circulation. Res.17: 106–113, 1965.
40.
WebsterM. E.: The Kinin System a review, in Cellular and Humoral Mechanisms in Anaphylaxis and Allergy, MovatH. Z., Ed., pp. 207–214, S. Karger, New York, 1969.
41.
WaalkesT. P., WeissbachH., BozicevichJ., and UdenfriendS.: Serotonin and Histamine Release During Anaphylaxis in Rabbit, J. Clin. Invest.36: 1115–1120, 1957.
42.
BendittE. P., WongR. L., AraseM., and RoeperE.: 5-Hydroxytryptamine in Mast Cells, Proc. Soc. Exp. Biol. Med.90: 303–304, 1955.
43.
BhattacharyaB. K., and LewisG. P.: The Release of 5-Hydroxytryptamine by Histamine Liberators, Brit. J. Pharmacol.11: 202–208, 1956.
44.
WestG. B.: Tissue Mast Cells and Tissue Amines, J. Pharm. Pharmacol.11: 513–534, 1959.
45.
ParrattJ. R., and WestG. B.: 5-Hydroxytryptamine and Tissue Mast Cells, J. Physiol. (Lond.).137: 169–178, 1957.
46.
UdenfriendS., and WaalkesT. P.: In: Mechanisms of Hypersensitivity, ShafferJ. H., LoGrippoG. A., and ChaseM. W., Eds. pp. 219–226, Little, Brown and Company, Boston, 1959.
47.
PiperP. J, and VaneJ. R.: Release of Additional Factors in Anaphylaxis and Its Antagonism by Anti-Inflammatory Drugs, Nature.223: 29–351969.
48.
CrunkhornP., and WillisA. L.: Cutaneous Reaction to Intradermal Prostaglandins, Brit. J. Pharmacol.41: 49–56, 1971.
49.
HortonE. W., and MainI. H.: A Comparison of the Actions of Prostaglandins F2a and El on Smooth Muscle, Brit. J. Pharmacol.24: 470–476, 1965.
50.
GoldsteinA., AronowL., and KalmanS. M.: Drug Allergy, in Principles of Drug Action, Harper and Row, New York, 1968, pp. 492.
51.
KahlsonG., and RosengrenE.: Histamine Formation in Hypersensitivity States, in Biogenesis and Physiology of Histamine, Edward Arnold, Ltd.London. 1971, pp. 198–207.
52.
BickermanH A.: Anti-Allergic Drugs, in Drugs of Choice, 1972-73.ModellW., Ed. C. V. Mosby Company, St. Louis, 1972, pp. 447.
53.
MillerR. L., and MelmonK. L.: Inflammatory Disorders, in Clinical Pharmacology, MelmonK. L., and MorelliH. F., Eds., MacMillan Co., New York, 1972, pp. 404.
54.
ValentineB. M. D.: Anaphylaxis, in Current Therapy, 1973.ConnH. F. Ed., W. B. Saunders Co.Philadelphia1973, pp. 530.
55.
MongarJ. L., and SchildH. O.: Cellular Mechanism in Anaphylaxis, Physiol. Rev.42: 226–270, 1962.
56.
SchildHo. O.: Histamine Release and Anaphylaxis in Histamine, WolstenholmeG. E. W., and O'ConnorC. M., Eds., Little, Brown & Co., Boston, 1956, pp. 142.
57.
ChattonM. J.: General Symptoms, in Current Diagnosis and Treatment, KruppM. A., and ChattonM. J., Eds., Lange Medical Publications, Los Altos, 1973, pp. 10–11.
58.
MashfordM. L., and ZacestR.: Effects of Adrenaline on Blood Kinin Levels and Blood Kininase Activity in Man, Circulation Res.21: 181–186, 1967.
59.
AviadoD. M., and CarrilloL. R.: Anti-Asthmatic Action of Corticosteroids: A Review of the Literature on Their Mechanism of Action, J. Clin. Pharmacol.103–111970.
60.
AlturaB. M.: Role of Glucocorticoids in Local Regulation of Blood Flow, Amer. J. Physiol.211: 1392–1395, 1966.
61.
FranklinW., MichelsonA. L., LowellF. C., and SchillerI. W.: Bronchodilators and Corticosteroids in the Treatment of Obstructive Emphysema, N. E. J. Med.258: 774–778, 1958.
62.
MelmonK. L., and ClineM. J.: Kinins, Amer. J. Med.43: 153–160, 1967.